- All sections
- C - Chemistrymetallurgy
- C12N - Microorganisms or enzymescompositions thereofpropagating, preserving, or maintaining microorganismsmutation or genetic engineeringculture media
- C12N 5/0783 - T cellsNK cellsProgenitors of T or NK cells
Patent holdings for IPC class C12N 5/0783
Total number of patents in this class: 12965
10-year publication summary
|
600
|
792
|
1030
|
1183
|
1273
|
1441
|
1299
|
1345
|
1293
|
781
|
| 2017 | 2018 | 2019 | 2020 | 2021 | 2022 | 2023 | 2024 | 2025 | 2026 |
Principal owners for this class
| Owner |
All patents
|
This class
|
|---|---|---|
| Immatics Biotechnologies GmbH | 1126 |
655 |
| Iovance Biotherapeutics, Inc. | 406 |
283 |
| The Regents of the University of California | 20842 |
276 |
| The Trustees of the University of Pennsylvania | 4432 |
229 |
| Board of Regents, The University of Texas System | 6149 |
159 |
| The United States of America, as represented by the Secretary, Department of Health and Human Services | 3014 |
157 |
| Memorial Sloan-Kettering Cancer Center | 2056 |
141 |
| Cellectis | 415 |
138 |
| Juno Therapeutics, Inc. | 517 |
119 |
| Baylor College of Medicine | 1010 |
115 |
| Immunitybio, Inc. | 511 |
114 |
| The Board of Trustees of the Leland Stanford Junior University | 6697 |
110 |
| Novartis AG | 10175 |
101 |
| Kite Pharma, Inc. | 453 |
98 |
| City of Hope | 1042 |
96 |
| H. Lee Moffitt Cancer Center and Research Institute, Inc. | 1032 |
91 |
| Autolus Limited | 268 |
85 |
| Takeda Pharmaceutical Company Limited | 2699 |
84 |
| Kyoto University | 2926 |
79 |
| Regents of the University of Minnesota | 2797 |
79 |
| Other owners | 9756 |